Compare MTEK & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MTEK | BGLC |
|---|---|---|
| Founded | 2008 | 2017 |
| Country | Israel | Malaysia |
| Employees | 16 | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1M | 3.8M |
| IPO Year | 2021 | 2019 |
| Metric | MTEK | BGLC |
|---|---|---|
| Price | $0.42 | $1.19 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 511.9K | 7.2K |
| Earning Date | 09-02-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.78 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $7,424,911.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.37 | $1.07 |
| 52 Week High | $2.82 | $5.65 |
| Indicator | MTEK | BGLC |
|---|---|---|
| Relative Strength Index (RSI) | 26.16 | 39.53 |
| Support Level | N/A | $1.07 |
| Resistance Level | $1.12 | $1.39 |
| Average True Range (ATR) | 0.05 | 0.06 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 14.87 | 4.76 |
Maris Tech Ltd is a B2B provider of intelligent video transmission technology with AI acceleration for edge platforms, using high-end digital video, audio, and wireless communication technologies. It designs, develops, manufactures, and commercially sells miniature intelligent video and audio surveillance and communication systems with AI acceleration for the professional, civilian, and home security markets. Its products and solutions are sold as off-the-shelf, standalone, and ready-to-use products, or as customized components that meet customers' requirements and integrate into their systems and products. Its customers include companies operating in the drone, robotic, defense, HLS, intelligence gathering, autonomous vehicle, and space markets. It generates maximum revenue from Israel.
BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.